Welcome & Thank You For Joining Us!

Allison Burnett

Anticoagulation Stewardship

Allison Burnett University of NM

Top Papers You Need to Know

Scott Kaatz, Tracy Minichiello

Tracy Minichiello UCSF

New Agents, New Indications

Mark Crowther McMaster University

Q&A Panel

Pre-Case (Special Situations)

Warfarin Management

Candace Bryant VA Sierra Nevada Healthcare System

Cancer and VTE

Marc Carrier Ottawa Hospital Research Institute

Women's Health

Sara Vazquez University of Utah Health

Clinic Administration

Andrea Van Beek Visalia Medical Clinic

Q&A

Post-Case

Pre-Case (The Vasculopathic Patient)

Treatment Strategies for PAD

Rachel Bond Dignity Health Medical Group

Speciality Perspective: Neurologist

S. Andrew Josephson UCSF

Speciality Pespective: Vascular Surgeon

Warren Gasper University of California San Francisco / San Francisco VA

Post-Case

Q&A

Pre-Case (Starting & Stopping Anticoagulation)

Impact of Pharmacist Led Anticoagulation Clinic in Cardiac Specialized Hospital

Reema Syed, Jibran Bin Yousuf National Institute of Cardiovascular Diseases, Karachi, Pakistan

Maximizing the Clinical Pharmacy Technician Role within a Centralized Anticoagulation Services Hub at the Veterans Health Administration

Sandra C Hedin, Melissa Fontana, Briana Ballister VA Great Lakes Health Care System, Westchester, IL, USA

Assessment of Pharmacists’ Intervention in the Initiation of a Direct Oral Anticoagulant (DOAC) Dashboard: Initial Phase

Nghi Ha, Elizabeth Renner, Denise Sutter-Long, Erin Mouland, Geoff Barnes, Michael Lanham Michigan Medicine, Ann Arbor, MI, USA

Multidisciplinary Approach in the Initiation of a Direct Oral Anticoagulant (DOAC) Dashboard

Erin Mouland, Nghi Ha, Denise Sutter-Long, Elizabeth Renner, Jackie Parsons Michigan Medicine, Ann Arbor, MI, USA

Warfarin-rifampin drug-drug-gene interaction (WARIF-G)

Muhammad Salem¹, Ahmed El-Bardissy¹, Mohamed Nabil Elshafei¹, Ahmed Khalil¹, Hesham Mahmoud¹, Amr Mohamed Fahmi^{1, 2}, Mohamed Kasem¹, Loulia Bader², Mohamed Sherbash^{1, 2}, Mostafa Ibrahim Elawady¹, Hazem Elewa^{2, 3 1}Clinical Pharmacy Department, Hamad Medical Corporation, Doha, Qatar.²College of Pharmacy, QU Health, Qatar University, Doha, Qatar.³Biomedical and Pharmaceutical Research Unit, Doha, Qatar

Protocolized critical INR management in a pharmacist-led anticoagulation clinic

Christi A Albert¹, Ethan Meyer^{1, 2}, Anne Rose^{1 1}UW Health, Madison, WI, USA.²University of Wisconsin-Madison School of Pharmacy, Madison, WI, USA

Barriers and Facilitators to Warfarin Patient Self-Management in the US Healthcare System

Aaron Wilson¹, Aubrey Jones¹, Stacey Slager², Sara Vazquez^{1, 3}, Ryan Fleming³, Geoffrey Barnes⁴, Katelyn Sylvester⁵, Linh Chan⁶, Bishoy Ragheb⁷, Jacob Kean⁸, Daniel Witt^{1 1}University of Utah College of Pharmacy, Salt Lake City, UT, USA.²University of Utah Office of Research Integrity and Compliance, Salt Lake City, UT, USA.³University of Utah Health, Salt Lake City, UT, USA.⁴University of Michigan, Ann Arbor, MI, USA.⁵Brigham and Women, Boston, MA, USA.⁶VA Loma Linda Healthcare System, Loma Linda, CA, USA.⁷VA Eastern Colorado Health Care System, Aurora, CO, USA.⁸University of Utah School of Medicine, Salt Lake City, UT, USA

Evaluating the Process of Transitioning Atrial Fibrillation (AF) Patients from Warfarin to a Direct Oral Anticoagulant (DOAC) in aPharmacist-led Anticoagulation Clinic

Mursal Noor, Chris Amadi, Mark Canevari, Kassandra Bugg UC Davis Health, Sacramento, CA, USA

Anticoagulant management of COVID-19 patients with thrombotic complications

Anish Joshi¹, Arushi Garud¹, Neha Thomas¹, Atul Laddu¹, Jawed Fareed^{2 1}Global Thrombosis Forum, Suwanee, GA, USA.²Loyola University, Chicago, IL, USA

Clinical and Genetic-Based Refinement of the Warfarin Dose

Noor Al-Hammadi^{1, 2}, Kevin B. Stephenson¹, Jie Hou³, Charles S. Eby^{1, 5}, Anne R. Bass⁴, Brian F. Gage^{1 1}Department of Medicine, Washington University in St. Louis, Saint Louis, MO, USA.²Department of Health and Clinical Outcomes Research, Saint Louis University, Saint Louis, MO, USA.³Department of Computer Science, Saint Louis University, Saint Louis, MO, USA.⁴Department of Medicine, Hospital for Special Surgery/Weill Cornell Medicine, New York, New York, NY, USA.⁵Department of Pathology and Immunology, Washington University in St. Louis, Saint Louis, MO, USA

Biomarkers of Hemostatic Dysregulation

Shivam Gupta¹, Divya Honavar¹, Neha Thomas¹, Atul Laddu¹, Jawed Fareed^{2 1}Global Thrombosis Forum, Suwanee, GA, USA.²Loyola University, Chicago, IL, USA

Utilization of a Direct Oral Anticoagulant Population Management Tool: Standardizing Assessment of Hemoglobin Flags

Heather Poepping¹, Julie Spenner¹, Michelle Anderson¹, Christina Bookwalter¹, Arthur Allen^{2 1}Minneapolis VA Health Care System, Minneapolis, MN, USA.²VA Salt Lake City Health Care System, Salt Lake City, UT, USA

Warfarin use is associated with higher rates of clinically relevant epistaxis compared to direct oral anticoagulants

Khristian S. Burke¹, Xiaowen Kong², Brian Haymart², Debbie DeCamillo², Mona Ali³, Geoff D. Barnes², Scott Kaatz^{4 1}Central Michigan University College of Medicine, Mount Pleasant, MI, USA.²Michigan Medicine, Ann arbor, MI, USA.³Beaumont Health System, Royal Oak, MI, USA.⁴Division of Hospital Medicine, Henry Ford Hospital, Detroit, MI, USA

Prevalence and Predictors of Underdosing in Patients Initiating Direct Oral Anticoagulants for Atrial Fibrillation or Venous Thromboembolism

Chloe Kazaglis¹, Xiaowen Kong¹, Brian Haymart¹, Xiaokui Gu¹, Deborah DeCamillo¹, Mona Ali², Scott Kaatz³, Geoffrey D Barnes^{1 1}Frankel Cardiovascular Center-University of Michigan Medicine Health, Ann Arbor, MI, USA.²William Beaumont Hospital, Royal Oak, MI, USA.³Henry Ford Hospital-Division of Hospital Medicine, Detroit, MI, USA

Characterization of Direct-Acting Oral Anticoagulants (DOAC) Dosing: A cross-sectional real-world evaluation of US patients with non-valvular atrial fibrillation

Mohammad B. Ateya, Timothy J Hartman, Jon Glover, Laura L Manzey, Lynette T Davis, Anna Gleboff, Bonnie DeLor Pfizer Inc., New York, NY, USA

Procedural/Surgical Rhythm Control for Patients with Atrial Fibrillation: A Meta-Analysis

Bryce Montane, Shiyang Zhang, Jonathan Wolfe, Sabrina Prime, Daniel Cooper, Michelle Doering, Brian Gage Washington University School of Medicine, St. Louis, MO, USA

Eligibility and Discussions of Left Atrial Appendage Occlusion in Patients on Anticoagulation for Atrial Fibrillation

Amber Co, Brian Haymart, Deborah DeCamillo, Geoffrey D Barnes University of Michigan Health, Frankel Cardiovasclar Center, Ann Arbor, MI, USA

Thrombogenicity of an Implantable Cardioverter Defibrillator lead Beats anticoagulation: A case report

Abdelsalam/S Elshaikh, Mohammed/A Wazzan, Ghassan/H Elkadi, Judith/A Mackall, Kelsey/E Gray, Dillon Gibson University Hospitals of Cleveland Medical Center, Cleveland, OH, USA

SARS-CoV-2 Infection and the Management of Long-term Warfarin Therapy

Lisa J. Mahoney¹, Joseph R. Flynn², Jan A. Anderson³, Kristin C. Mara³, Annette Faller¹, Harold J. Hellweg^{4 1}Mayo Clinic Health System, La Crosse, WI, USA.²Mayo Clinic Health System, Mankato, MN, USA.³Mayo Clinic, Rochester, MN, USA.⁴Mayo Clinic Health System, Owatonna, MN, USA

A population health approach to stroke prevention in atrial fibrillation/flutter: Targeting the untreated while prioritizing health disparities

Jeffery Kibert¹, Arthur Allen¹, T. Scott Wall¹, Linda Chia², Patrick Spoutz^{3 1}VA Salt Lake City Health Care System, Salt Lake City, UT, USA.²Veterans Integrated Service Network 8, St. Petersburg, FL, USA.³Veterans Integrated Service Network 20, Vancouver, WA, USA

Community-basedAntithrombotic Stewardship to Combat Health Disparities in Peripheral Artery Disease

Kristie Roberts, Kelly Rudd Oklahoma State University Center of Health Sciences, Tulsa, OK, USA

Scoping Review: Racial disparities in anticoagulation care delivery (interim data)

Sara R. Vazquez¹, Naomi Y. Yates², Craig Beavers³, Darren Triller⁴, Mary McFarland^{5 1}University of Utah Health .²Kaiser Permanente .³University of Kentucky College of Pharmacy .⁴Anticoagulation Forum .⁵University of Utah Eccles Health Sciences Library

A comparison of antifactor Xa (aFXa) nomograms and activated partial thrombin time (aPTT) nomograms for nurse driven systemic unfractionated heparin (UFH) infusions

Kaitlyn Loi Community Medical Centers, Fresno, CA, USA

Improving the Diagnosis and Management of Heparin Induced Thrombocytopenia (HIT) with Electronic Consultation

Jori May¹, K. Ria Hearld², Michael Denaburg³, Gretchen Kennamer⁴, Laura Taylor⁵, Marisa Marques^{6 1}Division of Hematology/Oncology, Department of Medicine, University of Alabama at Birmingham, Birmingham, AL, USA.²Department of Epidemiology, University of Alabama at Birmingham, Birmingham, AL, USA.³Department of Pharmacy, University of Alabama at Birmingham, Birmingham, AL, USA.⁴Clinical Informatics, University of Alabama at Birmingham, Birmingham, AL, USA.⁵Special Coagulation Service, University of Alabama at Birmingham, Birmingham, AL, USA.⁶Division of Laboratory Medicine, Department of Pathology, University of Alabama at Birmingham, Birmingham, AL, USA

Potential Drug-Drug Interactions with Anticoagulants among Post-Operated Patients of a Tertiary Cardiac Care Institute in Pakistan

Ahmad Ullah Humza¹, Abdul Hameed², Sadia Ghousia Baig³, Afshan Siddiq³, Attaullah Khan¹, Saima Salim¹, Jibran bin Yousuf^{1 1}National Institute of Cardiovascular Diseases (NICVD), Karachi, Pakistan.²Sindh Institute of Management a Technology (SMIT), Karachi, Pakistan.³Department of Pharmacology, University of Karachi, Karachi, Pakistan

Assessing the Implication of Increased Bleeding Risk Associated with Concurrent Use of Rivaroxaban and Dual P-gp Inhibitor and Moderate CYP3A4 Inhibitors.

Kisha A Dunkley¹, Elise Lee², Laura Calderon Lugo², Ashwini Niranjan-Azadi^{1 1}The Johns Hopkins Hospital, Baltimore, MD, USA.²Notre Dame of Maryland University, Baltimore, MD, USA

Identification of incorrect dosing of direct oral anticoagulants by ward pharmacists: a multidisciplinary approach to improve patient safety

Fiona Nagele, Emilie Tudela-Lopez, Michelle Hana, Martin Holbik, Simone Zotter, Maria Amtmann, Klara Jadrna, Petra Polzleitner, Ilse Pointner, Barbara Datterl, Maria Bachmann, Sonja Steininger-Salmer, Florian Pichler, Gerda Laml-Wallner, Gunar Stemer, Martina Anditsch Pharmacy Department of the University Hospital Vienna, Vienna, Austria

Leveraging Learners in the Education of Anticoagulated Patients - the LEAP Feasibility Pilot Study

Parsa Mahmoudi¹, Joseph Basi¹, Harriet Kusi², Amy L. Ives^{2, 3 1}Georgetown University School of Medicine, Washington, DC, USA.²MedStar Georgetown University Hospital, Washington, DC, USA.³University of Maryland School of Pharmacy, Baltimore, MD, USA

Homogeneous Enzyme Immunoassay for the Determination of Rivaroxaban in Human Plasma

Soon Oh, Moonbin Yim, Khanhlinh Pham, Rajendra Singh, Robert O'Malley, Tom Houts, Byung Moon, Johnny Valdez ARK Diagnostics, Fremont, CA, USA

INR Management in Antiphospholipid Syndrome Patient with Type II Secondary Arteriovenous Fistula

Jayllex N. Mills, H. Paige Erdeljac The Ohio State University, Columbus, OH, USA

Homogeneous Enzyme Immunoassay for the Determination of Apixaban in Human Plasma

Soon Oh, Jane Scheill, Khanhlinh Pham, Rajendra Singh, Robert O'Malley, Tom Houts, Byung Moon, Johnny Valdez ARK Diagnostics, Fremont, CA, USA

A case of persistently subtherapeuticantifactor Xa (aFXa) levels despiteheparin infusion dose uptitration in a patient with left ventricular assist device (LVAD)

Kaitlyn Loi Community Medical Centers, Fresno, CA, USA

Outcomes of Warfarin Home INR Monitoring vs Office-Based Monitoring: A Retrospective Claims-Based Analysis

Andrea Van Beek¹, Bishoy Ragheb², Erika Price^{3, 4}, Joanna MacEwan⁵, Mariola Moeyaert⁶, Jack Ansell^{7 1}Visalia Medical Clinic, Visalia, CA, USA.²VA Eastern Colorado Health Care System, Aurora, CO, USA.³San Francisco VA Health Care System, San Francisco, CA, USA.⁴University of California - San Francisco, Department of Medicine, San Francisco, CA, USA.⁵Genesis Research, Hoboken, NJ, USA.⁶University at Albany - SUNY, Albany, NY, USA.⁷Hofstra Northwell Zucker School of Medicine, Hempstead, NY, USA

Impact of Electronic Transmission of Patient PT/INR Home Self-Testing Results

Terea Williamson, DPT, BS¹, Stuart Blackwell, BA¹, Brittany Compton, BSN, RN¹, Paul Sommers, BSN, RN¹, Seok-Won Lee, PhD², Sandra Gomberg, DNP³, JoAnne Resnic, MBA, BSN, RN^{3 1}Orthodynamics Company, Inc. (ODI), Noblesville, IN, USA.²CoaguSense, Inc., Fremont, CA, USA.³Stel, Life, Inc, Philadelphia, PA, USA

A comparison of historical bridging practices within a single center with recommendations found in the 2022 updated enoxaparin bridging guidelines for patients on warfarin and an evaluation of bleeding rate

Khrystyna Hlukhenka¹, Michael Ellerbroek¹, Erin Carson^{1, 2}, Ammie Hodges^{1 1}University of Wisconsin-Madison (UW) Northern Illinois, Rockford, IL, USA.²University of Illinois Chicago, Chicago, IL, USA

2021 Encore: Successful Adaptation of the Management of Anticoagulation in the Peri-Procedural Period (MAPPP) Active Clinical Decision Support into a Nurse-Driven Protocol

Kelly Rudd¹, Robin Lopez², Penny Klingman^{2 1}Oklahoma State University Center for Health Sciences, Tulsa, OK, USA.²Bassett Healthcare Network, Cooperstown, NY, USA

Operationalizing Standardized Periprocedural Anticoagulation Management: A Stewardship Initiative

Kelly Rudd^{1, 2}, Amanda Winans², Darren Triller^{3 1}Oklahoma State University Center for Health Sciences, Tulsa, OK, USA.²Bassett Healthcare Network, Cooperstown, NY, USA.³The Anticoagulation Forum, Newton, MA, USA

Perioperative Management of Direct Oral Anticoagulants and Antiplatelet Therapy for Gastrointestinal Procedures

Rachel Fernandes, Tara Lech, Jana Montgomery Lahey Hospital and Medical Center, Burlington, MA, USA

What’s stopping you: Impact of anticoagulation on procedural delays and cancellations at an academic safety net hospital.

Smitha M John¹, Alyssa E Utz², Abdusebur Jemal¹, Emad Qayed³, Jason M Brown³, Mikhail Y Akbashev^{3 1}Morehouse School of Medicine, Atlanta, GA, USA.²Grady Memorial Hospital, Atlanta, GA, USA.³Emory University Department of Medicine, Atlanta, GA, USA

Development of clinical pharmacist led Anticoagulation stewardship program in cardiac care setting in developing country.

Sumaira khan¹, Dr bashir hanif¹, munazza qureshi¹, amna jenhangir^{1 1}Tabba Heart Institute, KARACHI, Pakistan.²Tabba Heart Institute, KARACHI, Pakistan.³Tabba Heart Institute, KARACHI, Pakistan.⁴Tabba Heart Institute, KARACHI, Pakistan

External validation of published heparin population pharmacokinetic models for model-informed precision dosing

Jasmine H. Hughes¹, Andrea N. Reed², Laura Frantz², Gerald J. Rebo², Jonathan D. Faldasz¹, Ron J. Keizer^{1 1}InsightRX, San Francisco, CA, USA.²Novant Health, Charlotte, NC, USA

Co-prescribing of Antiplatelets with Direct Oral Anticoagulants: A Medication Safety Initiative

David Parra^{1, 2}, Jeremy B. Sussman^{3, 4}, Jessica J. Lucas⁵, Janin Monterrey⁶, Litzalee Camacho-Vega⁶, Joseph J. Fierro⁷, Patricia Fernandez-Quevedo⁸, Maria Jose Irias⁸, Jaclyn Stoppi⁹, Robert D. Stewart¹⁰, Natalie R. Ciccone¹¹, Marissa N. Egipciaco¹¹, Briana S. Ballister¹², Charity S. Chen⁴, Jacob E. Kurlander^{3, 4}, for the VISN 8 PBM Pharmacy Anticoagulation Workgroup^{1 1}Veterans Health Administration VISN 8 Pharmacy Benefits Management, Bay Pines, FL, USA.²University of Minnesota, College of Pharmacy, Minneapolis, MN, USA.³University of Michigan, Ann Arbor, MI, USA.⁴Veterans Affairs Center for Clinical Management Research, Ann Arbor, MI, USA.⁵North Florida South Georgia Veterans Health Care System, Gainesville, DC, USA.⁶Caribbean Veterans Affairs Health Care System, San Juan, PR, USA.⁷Tamp Bay Veterans Affairs Health Care System, Tampa Bay, FL, USA.⁸Miami Veterans Affairs Health Care System, Miami, FL, USA.⁹West Palm Beach Veterans Affairs Health Care System, West Palm Beach, FL, USA.¹⁰Bay Pines Veterans Affairs Health Care System, Bay Pines, FL, USA.¹¹Orlando Veterans Affairs Health Care System, Orlando, FL, USA.¹²Veterans Health Administration Pharmacy Benefits Management VA MedSAFE, Washington, DC, USA

Implementation of a comprehensive perioperative anticoagulation management program leveraging the electronic health record at an academic medical center

Lisa J. Moherman, Valerie J. Brown, Kathryn Kasicky, Hannah B. Trickett West Virginia University (WVU) Medicine, Morgantown, WV, USA

Anti-Xa target attainment & dose selection: comparison of pharmacokinetic model-guided dosing versus institutional practice

Jasmine H. Hughes¹, Andrea N. H. Reed², Laura Frantz², Gerald J. Rebo², Jonathan D. Faldasz¹, Ron J. Keizer^{1 1}InsightRX, San Francisco, CA, USA.²Novant Health, Charlotte, NC, USA

Evaluating the Prevalence of Osteopenia or Osteoporosis in Veterans on Long-Term Warfarin Therapy

Julia Lee, Candace Bryant, Cecilia Gollaher VA Sierra Nevada Healthcare System, Reno, NV, USA

Antithrombosis Stewardship Within a Veterans Affairs Health System: Review of Combined Oral Anticoagulants and Antiplatelets

Candace Bryant¹, Spencer Davidson², Cecilia Gollaher¹, Rajendra Mishra^{3 1}VA Sierra Nevada Health Care System, Reno, NV, USA.²VA Durham Health Care System, Durham, NC, USA.³Magellan Rx, Phoenix, AZ, USA

Direct Oral Anticoagulants: An In-Depth Look at Harmful Events Reported to ECRI and the ISMP Patient Safety Organization

Jose Nery^{1, 2}, Matthew Grissinger^{1, 2 1}Institute for Safe Medication Practices, Plymouth Meeting, PA, USA.²ECRI, Plymouth Meeting, PA, USA

2021 Encore:National Board Certification as an Anticoagulation Care Provider: Barriers, Motivators and New CACP Recertification Processes

Kelly Rudd^{1, 2}, Lynn B. Oertel^{2, 3}, M. Jane Swartz⁴, Jennifer Palmer^{4 1}Oklahoma State University Center for Health Sciences, Tulsa, OK, USA.²National Certification Board of Anticoagulation Care Providers, Chicago, IL, USA.³Massachusetts General Anticoagulation Management Service, retired, Boston, MA, USA.⁴4University of Southern Indiana College of Nursing and Health Professions, Evansville, IN, USA

Antiplatelet De-escalation in Patients Receiving Oral Anticoagulants: Less Is More

Jennifer Crowley¹, Litzalee Camacho-Vega², Natalia Y. Ayala-Muniz^{3 1}Clinical Pharmacy Specialist-Cardiology, Veterans Affairs Caribbean Healthcare System, San Juan, PR, USA.²Clinical Pharmacist Specialist-Anticoagulation, Veterans Affairs Caribbean Healthcare System, San Juan, PR, USA.³Pharmacy PGY1 Resident 2021-2022, Veterans Affairs Caribbean Healthcare System, San Juan, PR, USA

Safe Timely resumption of Pharmacologic thromboembolism prevention in Hospitalized patients with A Recent Major Bleed

Harsh Sharma, Oksana Petrechko, David B. Jackson, Natasha Khan, Allison Burnett, Mindy Mason, Rachel Garcia, Taylor Goot, Christopher Bartlett, Jessica Zimmerberg-Helms University of New Mexico Health Sciences Center, Albuquerque, NM, USA

Aspirin deprescribing in patients on oral anticoagulation for atrial fibrillation or venous thromboembolism: A national survey of clinician practices

Sylvia Ou¹, Erin Pozzolano¹, Avisek Datta², Dulal Bhaumik², Nancy Shapiro^{1 1}Department of Pharmacy Practice, College of Pharmacy, University of Illinois at Chicago, Chicago, IL, USA.²Division of Epidemiology and Biostatistics, School of Public Health, University of Illinois at Chicago, Chicago, IL, USA

The challenges of patient activation: A pilot factorial trial examining multilevel interventions to reduce bleeding risk in patients prescribed combination antithrombotic therapy

Jacob E. Kurlander^{1, 2, 3}, Geoffrey D. Barnes^{1, 2, 4}, Danielle Helminski¹, Sarah L. Krein^{1, 2, 3}, Caroline R. Richardson⁵, Kelley M. Kidwell⁶, Liyang Yuan⁶, Michael Lanham^{7, 8, 9}, James B. Froehlich^{1, 2, 4}, Raymond De Vries^{2, 7, 11}, Linda K. Perry⁴, Jacqueline Parsons⁴, Nghi Ha⁴, Tina Alexandris-Souphis⁴, Joyce J. Kim¹, Sameer D. Saini^{1, 2, 3 1}Department of Internal Medicine, University of Michigan, Ann Arbor, MI, USA.²Institute for Healthcare Policy and Innovation, University of Michigan, Ann Arbor, MI, USA.³Veterans Affairs (VA) Ann Arbor Center for Clinical Management Research, Ann Arbor, MI, USA.⁴Frankel Cardiovascular Center, Department of Internal Medicine, University of Michigan, Ann Arbor, MI, USA.⁵Department of Family Medicine, Brown University, Providence, RI, USA.⁶Department of Biostatistics, University of Michigan School of Public Health, Ann Arbor, MI, USA.⁷Department of Learning Health Sciences, University of Michigan, Ann Arbor, MI, USA.⁸Department of Gynecology and Obstetrics, University of Michigan, Ann Arbor, MI, USA.⁹University of Michigan Office of Clinical Informatics, Ann Arbor, MI, USA.¹⁰Health Information Technology and Services, University of Michigan, Ann Arbor, MI, USA.¹¹Center for Bioethics and Social Sciences in Medicine, University of Michigan, Ann Arbor, MI, USA

The Nationwide Implementation of a Population Management Dashboard for Monitoring Direct Oral Anticoagulants: Insights from the Veterans Affairs Health System

Michael P. Dorsch^{1, 2, 3}, Charity S. Chen⁴, Arthur L Allen⁵, Anne E. Sales⁶, F. Jacob Seagull⁷, Patrick Spoutz⁸, Jeremy B. Sussman^{3, 4, 9}, Geoffrey D. Barnes^{2, 3, 9 1}College of Pharmacy, University of Michigan, Ann Arbor, MI, USA.²Frankel Cardiovascular Center, University of Michigan, Ann Arbor, MI, USA.³Institute for Healthcare Policy and Innovation, University of Michigan, Ann Arbor, MI, USA.⁴Ann Arbor Veterans Health Affairs, Ann Arboor, MI, USA.⁵Veterans Affairs Salt Lake City Health Care System, Salt Lake City, UT, USA.⁶School of Nursing, University of Missouri, Columbia, MO, USA.⁷Michigan Medicine - Center for Bioethics and Social Science in Medicine, University of Michigan, Ann Arbor, MI, USA.⁸VISN 20 Network Office, Veterans Health Affairs, Vancouver, WA, USA

The utility of an INR and best practice for monitoring DOAC therapy

Amber N Chiplinski¹, Emily A Bowman², Tessa A Keeting¹, Sarah M Pagenhardt¹, Marco Caccamo^{1 1}West Virginia University Medicine, Morgantown, WV, USA.²West Virginia University School of Pharmacy, Morgantown, WV, USA

Patient Compliance with Aspirin and Rivaroxaban post Elective Joint Replacement Surgery: A Quality Assurance Initiative

Laurie A. Sardo^{1, 2}, Julia A. Bayadinova^{1 1}St. Joseph's Healthcare Hamilton, Hamilton, ON, Canada.²McMaster University, Faculty of Nursing, Hamilton, ON, Canada

Measuring the Impact of VA Text Reminder Messages for Patients Taking Direct Oral Anticoagulants

Geri Kimura, Julia Whealin, Reese Omizo Department of Veteran Affairs Pacific Islands Health Care System, Honolulu, HI, USA

Medication Use Evaluation: Cangrelor for Percutaneous Coronary Intervention and Bridging

Jenni J. Klausen, Megan L. Robinson, Linh T. Nguyen, David D. Quach Bryan Medical Center, Lincoln, NE, USA

Cancer Associated Thrombosis: Optimizing the Prevention and Treatment in High Risk Cancer Patients

Nydia Khargie, Susan Jenkins, Erik Yeo University Health Network, Toronto, ON, Canada

Impact of Clinical Pharmacy Services on Direct Oral Anticoagulant Medication Selection and Dosing in the Ambulatory Care Setting

Naomi Y. Yates, Stephanie A. Hale Kaiser Permanente, Atlanta, GA, USA

Continuum of Stewardship: Oversight and Continual Process Improvement of a Population Management Tool in Veterans Health Administration

Jeffery L Kibert II¹, David Parra^2.3, Briana Ballister⁴, Von Moore⁵, Francesca Cunningham⁵, Arthur Allen¹, Patrick Spoutz^{6 1}VA Salt Lake City Health Care System, Salt Lake City, UT, USA.²Veterans Health Administration VISN 8 Pharmacy Benefits Management, Bay Pines, FL, USA.³University of Minnesota, College of Pharmacy, Minneapolis, MN, USA.⁴Veterans Health Administration Pharmacy Benefits Management VA MedSAFE, Washington, DC, USA.⁵Veterans Affairs Center for Medication Safety/Pharmacy Benefits Management Services, Hines, IL, USA.⁶Veterans Health Administration Northwest Health Network, Vancouver, WA, USA

Defining Success in Anticoagulation Stewardship: The Development of DOAC Population Health Management Quality Reports in Veterans Health Administration

Jennifer Vuong¹, Briana Ballister², Angela Casperson¹, Arthur Allen^{1 1}VA Salt Lake City Health Care System, Salt Lake City, UT, USA.²Veterans Health Administration Pharmacy Benefits Management VA MedSAFE, Washington, DC, USA.³VA Salt Lake City Health Care System, Salt Lake City, UT, USA.⁴VA Salt Lake City Health Care System, Salt Lake City, UT, USA

The Effect of a Multi-Healthcare Organization Quality Improvement Project on Aspirin Deprescribing

Noelle A Ryan¹, Geoff Barnes², Amanda Winans³, Jennifer Hardman⁴, Tara Lech⁵, Daniel Boldt⁶, Heather Eid⁷, Lauryl ristufek Hanf⁸, Krista Luck⁹, Alicia Wen¹⁰, Nancy Shapiro¹¹, Anya Gunn¹², Anne Rose¹³, Candace Bryant¹⁴, Kristy Shields¹⁵, Ryan Fleming^{16 1}Henry Ford Health, Detroit, MI, USA.²University of Michigan Medical Center, Ann Arbor, MI, USA.³Bassett Health, Cooperstown, NY, USA.⁴Froedtert Hospital, Milwaukee, WI, USA.⁵Lahey Hospital and Medical Center, Burlington, MA, USA.⁶Mercy Health, Grand Rapids, MI, USA.⁷Mercy Health St. Anne Hospital, Toledo, OH, USA.⁸Mercy Health St. Charles Hospital, Oregon, OH, USA.⁹Mission Hospital, Asheville, NC, USA.¹⁰Stanford Health Care and Clinics, Palo Alto, CA, USA.¹¹University of Illinois, Chicago, IL, USA.¹²University of Colorado Health Heart and Vascular Clinic, Steamboat Springs, CO, USA.¹³University of Wisconsin Medical Center, Madison, WI, USA.¹⁴VA Sierra Nevada Health Care System, Reno, NV, USA.¹⁵Waldo County General Hospital Anticoagulation Clinic, Belfast, ME, USA.¹⁶University of Utah Health, Sandy, UT, USA

Providers\' Perception of the Impact of COVID-19 on Warfarin Therapy Management

Mennat-Allah Abdin, John A. Saunders, Daniel M. Witt university of Utah, Salt Lake City, UT, USA

Improving the Understanding of Population Health-Based Digital Tools for Anticoagulation Management

Aaron S. Wilson¹, Darren M. Triller², Arthur Allen³, Allison Burnett⁴, Julie A. Gouveia-Pisano⁵, Allison Brenner⁵, Barbara K. Pritchard⁵, Charles Medico⁵, Sara R. Vazquez¹, Daniel M. Witt¹, Geoffrey D. Barnes^{6 1}University of Utah College of Pharmacy, Salt Lake City, UT, USA.²Anticoagulation Forum, Newton, MA, USA.³VA Salt Lake City Health Care System, Salt Lake City, UT, USA.⁴University of New Mexico Health Sciences Center, Albuquerque, NM, USA.⁵Pfizer Inc., New York City, NY, USA.⁶Frankel Cardiovascular Center, University of Michigan, Ann Arbor, MI, USA

Low Dose Prothrombin Complex Concentrate for Direct Oral Anticoagulant Reversal

Victoria Cancelliere¹, Ashley Mulvey², Anne Rose^{2 1}University of Wisconsin-Madison, School of Pharmacy, Madison, WI, USA.²University of Wisconsin Health, Madison, WI, USA

The Use of Andexanet Alfa Vs. Four Factor Prothrombin Complex Concentrates in the Reversal of Life-Threatening Intracranial Hemorrhage

Edward De Leo¹, Vivian Irizarry Gatell², Michael Bacchus¹, Yang Zhang¹, Carrie Lagasse¹, Anna Khanna¹, Neil Harris¹, Marc Zumberg^{1 1}University of Florida, Gainesville, FL, USA.²Moffitt Cancer Center, Tampa Bay, FL, USA

A Case of Dabigatran Accumulation with Hemorrhage and Coagulopathy

Jessica Greenberg¹, Ira Kraft², Khanh Nghiem³, Ali Elsaadi ⁴, Mei Li Kwong⁵, Shelley Kalsi^{6 1}Hematology Consult Section, Division of Intramural Research, National Heart Lung Blood Institute, Bethesda, MD, USA.²National Cancer Institute, Bethesda, MD, USA.³Hematology Section, Department of Laboratory Medicine, Clinical Center, National Institutes of Health, Bethesda, MD, USA.⁴Surgery Branch, Center for Cancer Research, National Cancer Institute, Bethesda, MD, USA.⁵Surgery Branch, Center for Cancer Research, National Cancer Institute, Bethesda, MD, USA.⁶Hematology Consult Section, Division of Intramural Research, National Heart Lung Blood Institute, Bethesda, MD, USA

Vascular Thrombosis in Antiphospholipid Syndrome Patient Despite Appropriate Anticoagulation Therapy

Yolanda McKoy-Beach¹, Peter Sealy², Sheeyra Upadhyay^{2 1}Howard University College of Pharmacy, Washington, DC, USA.²Howard University Hospital, Washington, DC, USA

Using Anti-Xa Monitoring to Manage Anticoagulation for Mechanical Heart Valves During Pregnancy

Annabel K. Frank, Margaret C. Fang University of California, San Francisco, San Francisco, CA, USA

Evaluation of Apixaban Anti-Xa Activity, Efficacy, and Safety Post-Bariatric Surgery

Katelyn M. Currier¹, Toby C. Trujillo¹, Jonathan A. Schoen², Rizwan Ahmed², Surabhi Palkimas^{1 1}University of Colorado Skaggs School of Pharmacy and Pharmaceutical Sciences, Aurora, CO, USA.²University of Colorado Hospital, Aurora, CO, USA

Pharmacist-Led, Checklist Driven Care Did Not Improve Adherence in Ambulatory Patients Starting or Resuming a Direct Oral Anticoagulant after Setback– The LEAVE Safe With DOACs Study

Aaron S Wilson, Thu Pham, Daniel Mbusa, Parth Patel, Soumya Chennupati, Sybil Crawford, Alok Kapoor UMass Chan Medical School, Worcester, MA, USA

2021 Encore:Operationalizing Efficient and Effectiveness Anticoagulation-Related Discharge Communication

Kelly Rudd¹, Brenda Davies-Wait², Chad Welch², Anna VanDerwerken^{2 1}Oklahoma State University Center for Health Sciences, Tulsa, OK, USA.²Bassett Healthcare Network, Cooperstown, NY, USA

Insurance Adjudication of Anticoagulants Prior to Discharge - Results from a Pilot Study

Joseph Basi¹, Parsa Mahmoudi¹, Harriet Kusi², Amy L. Ives^{2, 3 1}Georgetown University School of Medicine, Washington, DC, USA.²MedStar Georgetown University Hospital, Washington, DC, USA.³University of Maryland School of Pharmacy, Baltimore, MD, USA

Establishment and Utilization of an Advanced Practice Provider-Led Clinic for Newly Diagnosed Venous Thromboembolism

Cassi Frank, Raj Kasthuri, Nigel Key, Micah Mooberry, Stephan Moll University of North Carolina, Chapel Hill, Chapel Hill, NC, USA

Impact of Cancer on Outcome among Hospitalized Patients with Venous Thromboembolism: Data from National Inpatient Sample

Sijan Basnet¹, Biraj Shrestha², Luis H Eraso¹, Taki Galanis¹, Anthony Macchiavelli¹, Geno Merli^{1 1}Thomas Jefferson University Hospital, Philadelphia, PA, USA.²Reading Hospital, West Reading, PA, USA

Anticoagulation (AC) Clinical Pharmacy Practitioners (CPPs) Utilization of Direct Oral Anticoagulant (DOAC) Starter Packs in the Ambulatory Care Setting for Outpatient Treatment of Acute, Stable Deep Vein Thrombosis (DVT)

Bonnie J. Whittington, Kidest-Mimi A. Demesse, April Y. Allen VA North Texas Health Care System, Dallas, TX, USA

Direct Oral Anticoagulants for the Treatment of Splanchnic Vein Thrombosis - A Systematic Review and Meta-analysis

Allen Li^{1, 2}, Ming Zhang³, Harry Li⁴, Ali Eshaghpour⁵, Marc Carrier^{2, 6}, Philip Wells^{2, 6}, Mark Crowther^{5 1}The Ottawa Hospital Research Institute, The Ottawa Hospital, Ottawa, ON, Canada.²Faculty of Medicine, University of Ottawa, Ottawa, ON, Canada.³Michael G. DeGroote School of Medicine, Hamilton, ON, Canada.⁴Temerty Faculty of Medicine, University of Toronto, Toronto, ON, Canada.⁵Department of Medicine, McMaster University, Hamilton, ON, Canada.⁶Department of Medicine, University of Ottawa, Ottawa, ON, Canada

Thromboembolism Risk and Management Pattern in Hospitalized COVID-19 Patients: A Single-Center Experience in Ethiopia

Tamrat Assefa Tadesse, Ashenafi Teklu Addis Ababa University, Addis Ababa, Ethiopia

Attributes of Randomized Controlled Trials and Their Associations With Funding Source in Venous Thromboembolism Prophylaxis for Patients With Cancer: A Bibliographical Analysis

Jayhan A. Kherani¹, Lucy Zhao¹, Pei Y. Li², Kevin Zhang², Angelina Horta¹, Christine Lin¹, Allen Li³, Ali Eshaghpour⁴, Mark A. Crowther^{4 1}Faculty of Health Sciences, McMaster University, Hamilton, ON, Canada.²Temerty Faculty of Medicine, University of Toronto, Toronto, ON, Canada.³Faculty of Medicine, University of Ottawa, Ottawa, ON, Canada.⁴Department of Medicine, McMaster University, Hamilton, ON, Canada

Inferior Vena Cava Filter Use at a Large Community Hospital: A Cross-Sectional Analysis

Samantha Bolger¹, Kaity Greco¹, Yuxin Bai¹, Stephanie Fontyn¹, Caroline Hamm^{1, 2}, Andrea Cervi^{1, 2 1}Schulich School of Medicine and Dentistry, London, ON, Canada.²Department of Medical Oncology, Windsor Regional Cancer Centre, Windsor, ON, Canada

Significance of the Loading Phase Duration of Apixaban on Bleeding Events in Patients Treated for Newly Diagnosed Venous Thromboembolism After Initial Parenteral Anticoagulation Treatment

Lauren Jackson, Amanda Gillion, Jacob Marler Memphis VA Medical Center, Memphis, TN, USA